11 Agosto 2025

Recrutamento de primeiro doente assinala um marco importante num ensaio clínico, sobre o uso de psilocibina para efeitos terapêuticos, financiado pela UE

“Este é um passo histórico”, afirma Robert Schoevers, director do serviço de Psiquiatria do Centro Médico Universitário de Groningen (UMCG) e investigador principal do PsyPal. “Após muitos meses de preparação, estamos entusiasmados por começar a trabalhar directamente com doentes.”

Maria João Cardoso

04 Ago. 2025

Physiotherapist

Research
Início da Candidatura: 04 Ago. 2025

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Physiotherapist.

04 Ago. 2025

Research Technician

Research
Início da Candidatura: 04 Ago. 2025

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Research Technician.

Inês Faria

Gleb Gorodetskiy

Cátia Ramos

Psychedelic Therapy: From Evidence to Equity

This one-day event will bring together clinicians, researchers, patient representatives, policymakers and ethicists to explore the landscape of psychedelic-assisted care through the lens of the four pillars of medical ethics: beneficence, autonomy, non-maleficence, and justice.

The symposium will delve into safety, regulation, therapeutic practices, and future directions to ensure equitable access to psychedelic-assisted care.

Heitor Munhoz Österdahl

Medica AI - The Conference 2026

The future of medicine is being redefined by artificial intelligence. From digital twins and precision medicine to AI-driven medical imaging and large language models, cutting-edge technologies are transforming the way we diagnose, treat, and prevent disease.

Subscribe to Investigadores
Loading
Por favor aguarde...